THUNDER® Human CCL17/TARC TR-FRET Biomarker Assay Kit

Sandwich TR-FRET immunoassay for the quantitative measurement of human CCL17 (C-C motif chemokine 17; CC chemokine TARC) in cell culture supernatants, serum, plasma and blood. The kit does not include a recombinant human CCL17/TARC standard, which must be purchased separately from R&D Systems® (catalog number 364-DN). A detailed assay protocol and full assay validation can be found in the Technical Data Sheet. The assay is compatible with both adherent and suspension cells, and is run using a simple, rapid, and homogeneous protocol (no wash steps, no separation steps). BEST SELLER – FIRST TO MARKET

Product citation: Patent WO2025133961-A1 (Pfizer Inc.)

Key features and benefits:

• Homogeneous: no wash, easy and rapid protocol (1 hour incubation)
• High sensitivity (15 µL sample), specificity, robustness, and reproducibility
• A high-quality antibody pair specifically optimized for TR-FRET ensures assay performance and lot-to-lot consistency
• Reliable: rigorous development, validation, and quality control testing
• Cost-effective: 5 flexible formats
• Bulk quantities and single-lot reservation are available upon request
• For Research Use Only. Not for use in diagnostic procedures